MZI Resources flags improved production and price increases in 2017
In the course of providing its quarterly activities update for the three months to December 31, 2016, mineral sands producer MZI Resources highlighted a number of records achieved for the quarter and suggested increased production from its Keysbrook project in Western Australia and an improved pricing environment would assist in driving revenues in 2017.
Reflecting on the three months to December 31, 2016, one of the most promising achievements was a 21% increase in the group’s production of high-value L88 leucoxene product.
While port congestion delayed a planned shipment of lower value L70 leucoxene in December, the benefits of this will fall into the March quarter.
It should be noted, however, that any further catalysts are speculative at this stage and should not be taken as guaranteed. Investors should seek professional financial advice for further information.
Production improvements sustainable
From an operational perspective, one of the key outcomes was the material improvement in overall production and on this note MZI’s interim Managing Director, Steve Ward said, “The December quarter was one of special significance for MZI, during which the Keysbrook Wet Concentrator Plant (WCP) achieved critical design performance milestones following the recently completed optimisation project”.
Ward noted that the optimisation project had quickly proven its worth and that the improved production was sustainable, validating the group’s investment.
MZI expects that the improvements at Keysbrook should flow through to the performance of the company’s Picton mineral separation plant when the next processing campaign commences in late January.
Industry conditions improving
Commenting on industry dynamics, Ward said, “Importantly, Keysbrook is starting to hit its straps at the right time, with the market outlook for mineral sands, including higher value products such as Keysbrook leucoxene, continuing to strengthen”.
On this note, MZI highlighted the fact that pigment producers are now seeing improvement in both volumes and price which is depleting inventory. Of further significance is the announcement of 13 rounds of price increases by Chinese producers in 2016.
Importantly for MZI, demand for chloride pigment has also resulted in reduced inventory levels and put upward price pressure on high-titanium dioxide feedstock such as rutile and leucoxene.
Here are MZI’s milestones for the past 12 months:
When the experts at Next Investors have a stock pick, it may pay to listen.
The Next Investors have been investing in ASX small cap stocks for years, with their best small cap picks yielding returns of 1,200%, 1,120%, 900% and 678%.
They have just revealed their hand-picked, FY2021 stock portfolio of high conviction long-term investments.
Click the link below to see what they are currently investing in.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.